Literature DB >> 4332311

A new human cell line (FaDu) from a hypopharyngeal carcinoma.

S R Rangan.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4332311     DOI： 10.1002/1097-0142(197201)29:1<117::aid-cncr2820290119>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  79 in total

1.  Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro.

Authors:  Wiebke Laffers; Ann-Christin Busse; Jens Mahrt; Phuc Nguyen; Andreas O H Gerstner; Friedrich Bootz; Johannes T Wessels
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-01       Impact factor: 2.503

2.  HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel P Camarco; Tong Ying Shun; John S Lazo; Gabriela Mustata Wilson; Lynn O Resnick; Matthew G LaPorte; Peter Wipf; Donna M Huryn; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2015-09       Impact factor: 1.738

3.  High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel Camarco; Tong Ying Shun; John S Lazo; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2013-10-15       Impact factor: 1.738

4.  Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Authors:  Andre Cassell; Maria L Freilino; Jessica Lee; Sharon Barr; Lin Wang; Mary C Panahandeh; Sufi M Thomas; Jennifer R Grandis
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

5.  Interstitial diffuse optical probe with spectral fitting to measure dynamic tumor hypoxia.

Authors:  Leonard Che Fru; Steven L Jacques; Kwang P Nickel; Tomy Varghese; Michael W Kissick; Larry A DeWerd; Randall J Kimple
Journal:  Biomed Phys Eng Express       Date:  2020-01-31

6.  Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.

Authors:  Sanjay Chandrasekaran; Maiko Sasaki; Christopher D Scharer; Haydn T Kissick; Dillon G Patterson; Kelly R Magliocca; John T Seykora; Bishu Sapkota; David A Gutman; Lee A Cooper; Gregory B Lesinski; Edmund K Waller; Susan N Thomas; Sergei V Kotenko; Jeremy M Boss; Carlos S Moreno; Robert A Swerlick; Brian P Pollack
Journal:  Mol Cancer Res       Date:  2019-09-23       Impact factor: 5.852

7.  Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait.

Authors:  M Reiss; T Muñoz-Antonia; J M Cowan; P C Wilkins; Z L Zhou; V F Vellucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

9.  p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.

Authors:  Lars R Perk; Maria J W D Vosjan; Gerard W M Visser; Marianne Budde; Paul Jurek; Garry E Kiefer; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-18       Impact factor: 9.236

10.  (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.

Authors:  Bernard M Tijink; Lars R Perk; Marianne Budde; Marijke Stigter-van Walsum; Gerard W M Visser; Reina W Kloet; Ludger M Dinkelborg; C René Leemans; Dario Neri; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.